C07D 263/32
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D263/32 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 1,085 US grants and 1,078 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,085
- Published applications
- 1,078
- Assignees
- 538
- Inventors
- 3,829
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 6 | 0 |
| 1978 | 6 | 0 |
| 1979 | 7 | 0 |
| 1980 | 10 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 5 | 0 |
| 1985 | 2 | 0 |
| 1986 | 6 | 0 |
| 1987 | 6 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 8 | 0 |
| 1991 | 7 | 0 |
| 1992 | 9 | 0 |
| 1993 | 23 | 0 |
| 1994 | 17 | 0 |
| 1995 | 19 | 0 |
| 1996 | 22 | 0 |
| 1997 | 32 | 0 |
| 1998 | 21 | 0 |
| 1999 | 38 | 0 |
| 2000 | 21 | 0 |
| 2001 | 30 | 7 |
| 2002 | 42 | 35 |
| 2003 | 45 | 48 |
| 2004 | 28 | 81 |
| 2005 | 29 | 71 |
| 2006 | 42 | 48 |
| 2007 | 36 | 67 |
| 2008 | 34 | 56 |
| 2009 | 33 | 53 |
| 2010 | 42 | 55 |
| 2011 | 37 | 48 |
| 2012 | 29 | 39 |
| 2013 | 46 | 50 |
| 2014 | 42 | 54 |
| 2015 | 41 | 46 |
| 2016 | 42 | 34 |
| 2017 | 29 | 38 |
| 2018 | 23 | 23 |
| 2019 | 18 | 26 |
| 2020 | 21 | 30 |
| 2021 | 13 | 37 |
| 2022 | 29 | 31 |
| 2023 | 21 | 39 |
| 2024 | 22 | 28 |
| 2025 | 9 | 22 |
| 2026 | 8 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium19 May 2026US 12,630,542 B2Endogena Therapeutics, Inc.
- Modifier of four-membered ring derivative, preparation method and application thereof5 May 2026US 12,617,759 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Carboxy derivatives with antiinflamatory properties5 May 2026US 12,617,762 B2Sitryx Therapeutics Limited
- Glutamine analogs17 Mar 2026US 12,577,201 B2Jacobio Pharmaceuticals Co., Ltd.
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Nematicidal compounds, their composition and use thereof13 Aug 2026US 2026/0231945 A1
- Compounds, their composition and their use as nematicides13 Aug 2026US 2026/0234101 A1
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
- Modulators of mitochondrial dna replication21 May 2026US 2026/0138961 A1Pretzel Therapeutics, Inc.
Most cited
By later US patents
- Inhibitors of IMPDH enzyme190US 5,807,876 AVertex Pharmaceuticals Incorporated · 1998
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Heterocyclic containing biphenyl aP2 inhibitors and method135US 6,548,529 B1Bristol-Myers Squibb Company · 2003
- Inhibitors of IMPDH enzyme127US 6,054,472 AVertex Pharmaceuticals Incorporated · 2000
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994